Intec Becomes Latest Parkinson's Drug Maker To Eye IPO
Intec Pharma Ltd. laid the groundwork to go public in the U.S. on Wednesday, establishing the Israel-based drug delivery developer as the latest IPO-bound biopharmaceutical company with a Parkinson's disease treatment...To view the full article, register now.
Already a subscriber? Click here to view full article